FDA authorizes two rapid, at-home COVID-19 tests in major move
Story Date: 4/2/2021

 

Source: MSN, 4/1/21


The Food and Drug Administration (FDA) late Wednesday authorized rapid tests from two companies in a major step forward for the availability of at-home COVID-19 testing. The authorizations of the Quidel QuickVue and Abbott BinaxNOW tests will allow people to swab themselves at home and get results in minutes. The Quidel test delivers results in 10 minutes and the Abbott test requires 15 minutes. While the FDA has previously taken some steps toward authorizing at-home tests, advocates hailed the new ...

For more of this story, click here


























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.